Mylan Sues FDA for Rights to Generic Medication

By Bowling, Brian | Tribune-Review/Pittsburgh Tribune-Review, April 6, 2012 | Go to article overview
Save to active project

Mylan Sues FDA for Rights to Generic Medication


Bowling, Brian, Tribune-Review/Pittsburgh Tribune-Review


Mylan Inc. claimed in a federal lawsuit filed on Thursday in the District of Columbia that the Food and Drug Administration should have awarded its Mylan Pharmaceuticals Inc. unit, rather than a competitor, the exclusive right to sell a generic version of Provigil for the next six months.

Provigil is the brand name for modafinil, a drug used to improve wakefulness in people who have trouble staying awake because of narcolepsy, obstructive sleep apnea or working night shifts or rotating shifts.

Mylan Pharmaceuticals of Morgantown, W.Va., is a subsidiary of Canonsburg-based Mylan Inc.

The FDA awarded the 180-day exclusivity to Jerusalem-based Teva Pharmaceutical Industries Ltd. Teva bought Cephalon Inc., the manufacturer of Provigil, in 2011. Cephalon is based in Chester County, near Philadelphia. Provigil has more than $1 billion in annual sales, according to Teva.

Mylan contends that Teva's purchase of the company holding the two patents for Provigil makes it ineligible to hold the exclusive right to sell the generic version for the next six months.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

Mylan Sues FDA for Rights to Generic Medication
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?